Arginine vasopressin to manage hypoxemic infants after stage I palliation of single ventricle lesions

Abstract

In patients with single ventricle physiology and persistent hypoxemia following stage I palliation, administration of arginine vasopressin could improve oxygenation possibly by increasing systemic vascular resistance and therefore the pulmonary blood flow.